Idiopathic pulmonary fibrosis (IPF) is a chronic, progressive scarring interstitial lung disease
with an unknown cause. Some patients may experience acute exacerbations (AE), which …

Radiation-induced pulmonary fibrosis (RIPF) is a chronic and progressive respiratory tract
disease characterized by collagen deposition. The pathogenesis of RIPF is still unclear …

Matrix assisted laser desorption/ionization imaging has greatly improved our understanding
of spatial biology, however a robust bioinformatic pipeline for data analysis is lacking. Here …

Pulmonary fibrosis is a chronic interstitial lung disease that causes irreversible and
progressive lung scarring and respiratory failure. Activation of fibroblasts plays a central role …

Abstract Background and Purpose Nitazoxanide is a therapeutic anthelmintic drug. Our
previous studies found that nitazoxanide and its metabolite tizoxanide activated adenosine …

The coexistence of lung adenocarcinoma (LUAD) with idiopathic pulmonary fibrosis (IPF),
which has been extensively documented as a prominent risk factor for checkpoint inhibitor …

Idiopathic pulmonary fibrosis (IPF) is a devastating interstitial lung disease with a bleak
prognosis. Mounting evidence suggests that IPF shares bio-molecular similarities with lung …

Acute lung injury leads to the development of chronic conditions such as idiopathic
pulmonary fibrosis (IPF), chronic obstructive pulmonary disease (COPD), asthma as well as …

The lung epithelium is constantly exposed to harmful agents present in the air that we
breathe making it highly susceptible to damage. However, in instances of injury to the lung, it …

Background Pulmonary fibrosis is a major category of end-stage changes in lung diseases,
characterized by lung epithelial cell damage, proliferation of fibroblasts, and accumulation of …